ACU-HHY-011

N/A

Report date: 2024/11/29 16:57:21

NME

Base Information

Drug NameACU-HHY-011

Drug Alias NameACU-HTR-028ACU-XSP-001OPK-HVB-004OPK-HVB-010

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionVascular endothelial growth factor inhibitors

TargetsVascular endothelial growth factor

Therapy Area/IndicationsInflammationHypersensitivityEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOpko Health Inc

China Registration ClassN/A

Active CompaniesOpko Health Inc

Inactive CompaniesN/A

Active IndicationsInflammationHypersensitivityEye Diseases

Inactive IndicationsN/A

ATC CodeN/A